The CTA application for the overseas clinical trial was submitted by IPIX on or before November 16, 2020 according to the PR that day. According to the timelines found on the link below, it is typically 60 days before notification (which appears to mean notification of approval to initiate the trial). It can be a shorter timeframe (I would assume a pandemic would warrant a shorter review period), so hopefully, we will hear about that approval soon as well.



https://ispe.org/pharmaceutical-engineering/i...on-process